Vestal Point Capital »

Reneo Pharmaceuticals shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Reneo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Reneo Pharmaceuticals held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reneo Pharmaceuticals by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $823k 545k 1.51

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Reneo Pharmaceuticals

NEA Management Company
Tang Capital Management
Highbridge Capital Management
Carlyle
BML Capital Management
RiverVest Venture Management
Octagon Capital Advisors
Aisling Capital Management
Vanguard Group
Nantahala Capital Management
Vestal Point Capital
Aldebaran Capital
Renaissance Technologies
Acuitas Investments
BlackRock

View all funds holding Reneo Pharmaceuticals